Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1995-06-07
1998-12-01
Wortman, Donna
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
435 5, 436518, 436820, 530324, 530328, 530403, A61K 3912, G01N 33576
Patent
active
058434500
ABSTRACT:
Hepatitis GB Virus (HGBV) synthetic peptides useful for a variety of diagnostic and therapeutic applications, kits for using the HGBV nucleic acid or amino acid sequences and antibodies which specifically bind to HGBV. Also provided are methods for producing antibodies, polyclonal or monoclonal, from the HGBV peptides.
REFERENCES:
patent: 4743535 (1988-05-01), Carrico
patent: 4876187 (1989-10-01), Duck et al.
patent: 5275947 (1994-01-01), Arima et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5527669 (1996-06-01), Resnick et al.
patent: 5576302 (1996-11-01), Cook et al.
S. Chan et al., Journal of General Virology, 73: 1131-1141 (1992).
A.S. Muerhoff et al., "Genomic Organization of GB Viruses A and B: Two New Members of the Flaviviridae Associated with GB Agent Hepatitis", Journal Of Virology, vol. 69, No. 9, (1995), pp. 5621-5630.
T. Gura, "Antisense Has Growing Pains", Science, vol. 270, (1995), pp. 575-577.
D. Brown, "Gene Therapy `Oversold` by Researchers, Journalists", Washington Post, (Dec. 8, 1995), pp. 1 & A22.
Choo et al., Proc. Natl. Acad. Sci. USA, vol. 88, pp. 2451-22455 (1991).
Okamoto et al., "Polyprotein precursor -hepatitis C virus", EMBL Sequence Accession No. S40770, Submitted Mar. 1992.
Okamoto et al., Virology, vol. 188, pp. 331-341 (1992).
S. K. Kuwada et al., The American Journal of Gastroenterology, vol. 89, No. 1, pp. 57-61 (1994).
A. S. Muerhoff et al., Journal of Virological Methods, vol. 62, No. 1, pp. 55-62 (1996).
A. Takamizawa et al., Journal of Virology, vol. 65, No. 3, pp. 1105-1113 (1991).
B. Bassam, DNA amplification fingerprinting of bacteria, Applied Microbiology and Biotechnology vol. 38: pp. 70-76 (1992).
G. Caetano-Anolles et al., DNA Amplification Fingerprinting of Using Very Short Aribitrary Oligonucleotide Primers, Biotechnology vol. 9: pp. 553-557 (1991).
J. Welsh et al., Fingerprintinggenomes using PCR with arbitrary primers*, Acids Research vol. 20 No. 19: pp. 4965-4970.
J. Williams et al., DNA polymorphisms amplified by arbitrary primers are useful as genetic markers, Nucleic Acids Research vol. 18 No. 22: pp. 6531-6535 (1990).
P. Liang et al., Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction, Science vol. 257: pp. 967-971 (1992).
P. Liang et al., Distribution and cloning of eukaryotic mRNAs by means of diferential display: refinements and optimization, Nucleic Acids Research vol. 21 No. 14: pp. 3269-3275 (1993).
J. Simons et al., Indentification of two flavivirus-like genomes in the GB Hepatitis agent, Ppoc. Natl. Acad. Sci. USAvol. 92: pp. 3401-3405 (1995).
J. Simons et al., Isolation of novel virus-like sequences associated with human hepatitis, Nature Medicinevol. 1 No. 6: pp. 564-568 (1995).
G. Schlauder et al., Molecular and Serologic Analysis in the Transmission of the GB Hepatitis Agents, Journal of Medical Virologyvol. 46: pp. 81-90 (1995).
M. Yoshiba et al., Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology,The Lancetvol. 346: pp. 1131-1132 (1995).
J. Linnen et al., Molecular Cloning and Disease Association of Heatitis G Virus: A Transfusion-Transmissible Agent, Sciencevol. 271: pp. 505-508 (1996).
A. Zuckerman, Tnew GB hepatitis viruses, The Lancet vol. 345: pp. 1453-1455 (1995).
L. Altman, Three Newly Discovered Viruses May Cause Unexplained Hepatitis, The New York Times Medical Science, Apr. 11, 1995.
L. Altman, Newly Found Viruses May Cause Hepatitis, The New York Times Medical Science, Apr. 10, 1995.
T. Leary et., Sequence and Genomic Organization of GBV-C: A novel Member of the Flavivirdae Associated With Human Non-A-E Hepetitis, Journal of Medical Virology vol. 48: pp. 80-87 (1996).
G. Caetano-Anolles et al., DNA Amplification Fingerprinting Using Arbitrary Oligonucleotide Primers, Applied Biochemistry and Biotechnology vol. 42: pp. 189-200 (1993).
S. Friedman et al., The core element of the EcoRII methylase as defined by protease digestion and deletion analysis, Nucleic Acids Research vol. 19 No. 19: p. 5403-5408 (1991).
A. Rosenthal et al., Genomic walking and sequencing by oligo-cassette mediated polymerase chain reaction, Nucleic Acids Research vol. 18 No 10: p. 3095-3096 (1990).
A. Akowitz, Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease, Archives of Virology vol. 130: p. 301-316 (1993).
Non-A, Non-B?, The Lancet vol. 2: pp. 64-65 (1975).
F. Hollinger, Non-A, Non-B Hepatitis Viruses, Virology : pp. 2239-2273 (1990).
J. Dienstag, Non-A, Non-B Hepatitis I. Recongnition, Epidemiology, and Clinical Features, Gastroenterology vol. 85 No. 2: pp. 439-462 (1983).
J. Strauss et al., Structure and Function of the Flavivirus and Pestivirus Genomes, Viral Hepatitis and Liver Disease: pp. 333-344 (1990).
H. Alter et al., Posttransfusion Hepatitis After Exclusion of Commercial and Hepatitis-B Antigen-Positive Donors, Annals of Internal Medicine vol. 77 No. 5: p. 691-699 (1972).
H. Alter et al., Clinical and Serological Analysis of Transfusion-Associated Hepatitis, The Lancet: pp. 838-841 (1975).
S. Feinstone et al., Transfusion-Associated Hepatitis Not Due To Viral Hepatitis Type A or B, The New England Journal of Medicine vol. 292 No. 15: pp. 767-770 (1975).
S. Feinstone et al., Hepatitis A: Detection by Immune Electron Microscopy of a Viruslike Antigen Associated with Acute Illness, Science vol. 182: p. 1026-1028 (1973).
E. Tabor et al., Lack of Susceptibility of Marmosets to Human Non-A, Non-B Hepatitis, The Journal of Infectious Diseases vol. 140 No. 5: pp. 794-797 (1979).
E. Fagan et al., Toga Virus-Like Particles in Acute Liver Failure Attributed to Sporadic Non-A, Non-B Hepatitis and Recurrence After Liver Transplantation, Journal of Medical Virology vol. 38: pp. 71-77 (1992).
J. Dienstage, Virus particles in marmoset hepatitis, Nature vol. 267: pp. 729-730 (1977).
F. Deinhardt et al., Hepatitis in Marmosets, The Journal of Infectious Diseases vol. 121 No. 3: pp. 351-354 (1970).
F. Deinhardt et al., The Mythology of Various Hepatitis A Virus Isolates, International Symposium on Viral Hepatitis: pp. 390-404 (1975).
M. Alter et al., The Natural History of Community-Acquired Hepatitis C in the United States, The New England Journal of Medicine vol. 327 No. 27: pp. 1899-1905 (1992).
R. Gibbs, Polymerase chain reaction techniques, Analytical Biotechnology: pp. 69-75 (1991).
F. Deinhardt et al., Hepatitis in marmosets, The American Journal of the Medical Sciences vol. 270: p. 73-80 (1975).
S. Kalter, Comparison of Infectivity of Human Non-A/Non-B Hepatitis and the GB Hepatitis Agent in Marmosets, Viral and Immunological Diseases in Nonhuman Primates;: pp. 221-224 (1983).
E. Tabor et al., Transmission of Human Non-A, Non-B Hepatitis to Chimpanzees following Failure to Transmit GB Agent Hepatitis, Journal of Medical Virology: pp. 103-108 (1980).
D. Bradley et al., Posttransfusion Non-A, Non-B Hepatitis: Physicochemical Properties of Two Distinct Agents, The Journal of Infectious Disease vol. 148 No. 2: pp. 254-265 (1983).
J. Deinstag, Virus-like particles and GB agent hepatitis, Nature vol. 264: pp. 260-261 (1976).
P. Karayiannis et al., Studies of GB Hepatitis Agent in Tamarins, Hepatology vol. 9 No. 2: pp. 186-192 (1989).
J. Melnick, Classification of Hepatitis A Virus as Enterovirus Type 72 and of Hepatitis B Virus as Hepadnavirus Type 1, Intervirology vol. 18: pp. 105-106 (1982).
W. Parks et al., Characterization of Marmoset Hepatitis A Virus, The Journal of Infectious Diseases vol. 120 No. 5: p. 548-559 (1969).
Heptitis C virus upstanding, The Lancet vol. 335: pp. 1431-1432 (1990).
W. Parks et al., Attempted Isolation fo Hepatitis Viruses in Marmosets, The Journal of Infectious Diseases vol. 120 No. 5: 539-547 (1969).
A. Holmes et al., Specific Neutralization of Human Hepatitis Type A in Marmoset Monkeys, Nature vol. 243: pp. 419-420 (1973).
P. Provost et al., Physical, Chemical and Morphologic Dimensions of Human Hepatitis A Virus Strain CR326 (38578), Proceeding of the Society for Experimental Biology and Medicine vol. 148: pp. 532-539 (19
Bridon Dominique P.
Dawson George J.
Jaffe Keeve D.
Knigge Mark F.
Mushahwar Isa K.
Abbott Laboratories
Casuto Dianne
Porembski Priscilla E.
Wortman Donna
LandOfFree
Hepatitis GB Virus synthetic peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis GB Virus synthetic peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis GB Virus synthetic peptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2393524